Protein to fight cancer

The protein therapy disrupts the process that causes cancer cells to break away from original tumour sites, travel through the blood stream and start aggressive new growths elsewhere in the body.

September 22, 2014 06:28 pm | Updated 06:28 pm IST

Today doctors try to slow or stop metastasis with chemotherapy, but these treatments are unfortunately not very effective and have severe side effects.

Today doctors try to slow or stop metastasis with chemotherapy, but these treatments are unfortunately not very effective and have severe side effects.

A protein therapy may soon offer a safe and effective alternative to chemotherapy that doctors today apply to try to slow or stop cancer from spreading. The experimental therapy has been shown to stop spread of breast and ovarian cancers in mice. The protein therapy disrupts the process that causes cancer cells to break away from original tumour sites, travel through the blood stream and start aggressive new growths elsewhere in the body, a process known as metastasis that can cause cancer to spread with deadly effect, the findings showed. “This is a very promising therapy that appears to be effective and non-toxic in pre-clinical experiments,” said co-researcher Amato Giaccia, a professor at the Stanford University in the US. “It could open up a new approach to cancer treatment,” Giaccia added. Today doctors try to slow or stop metastasis with chemotherapy, but these treatments are unfortunately not very effective and have severe side effects. The researchers sought to stop metastasis by preventing two proteins — Axl and Gas6 — from interacting to initiate the spread of cancer. Axl proteins stand like bristles on the surface of cancer cells, poised to receive bio-chemical signals from Gas6 proteins.

When two Gas6 proteins link with two Axls, the signals that are generated enable cancer cells to leave the original tumour site, migrate to other parts of the body and form new cancer nodules. To stop this process, the researchers used protein engineering to create a harmless version of Axl that acts like a decoy.

This decoy Axl latches on to Gas6 proteins in the blood stream and prevents them from linking with and activating the Axls present on cancer cells. The researchers gave intravenous treatments of this bio-engineered decoy protein to mice with aggressive breast and ovarian cancers. Mice in the breast cancer treatment group had 78 percent fewer metastatic nodules than untreated mice. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein.

The study appeared in the journal Nature Chemical Biology .

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.